Alloy Therapeutics Inc. ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

SNY's reasonable valuation, improving top-line performance, contributions from new product launches and positive pipeline ...

Australian CEOs are often shy to talk about how and when they use external consultants. The boss of this big French company, ...

Sanofi SA (SNY) stock saw a modest uptick, ending the day at $49.19 which represents a slight increase of $1.04 or 2.16% from the prior close of $48.15. The stock opened at $48.57 and touched a low of ...

Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level Mr. Shah Coherent Market Insights Pvt.

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

Neither coffee drinking pattern was tied to more or less cancer-specific mortality.

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the ...